ScholarWorks@Korea University: Cha, Dae Ryong

Detailed Information

Cha, Dae Ryong (차대룡)

College of Medicine (Department of Medical Science)

Research Area

Tel 산4886
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

diabetic nephropathy:7||fibrosis:6||Diabetic nephropathy:6||inflammation:6||insulin resistance:3||oxidative stress:3||kidney:3||SH3YL1:3||Fibrosis:3||biomarker:2||Visfatin:2||Diabetes mellitus:2||diabetic complication:2||diabetes:2||DPPIV inhibitor:2||APX115:2||nuclear factorkappa B:2||Diabetic kidney disease:2||glucose transporter1:2||Diabetic nephropathies:2||Glomerulosclerosis:2||type 2 diabetes mellitus:2||diabetes mellitus:2||albumin:2||phase III study:2||transforming growth factor beta:1||TLR4:1||renal fibrosis:1||Chronic kidney disease:1||aliskiren:1||renal lipid metabolism:1||visfatin:1||polymorphism:1||DPP4:1||Chemokine CCL2:1||Retinolbinding protein:1||Pancreatic stellate cells:1||Farnesoid Xactivated receptor:1||Purinergic P1 receptors:1||Purinergic P1 receptor antagonists:1||cytokine:1||tubular damage:1||Adipokines:1||Mouse Model:1||retinoic acid:1||LC150444:1||leptin:1||ICAM1:1||Vascular endothelial growth factor:1||ADIPOSETISSUE:1||Nicotinamide phosphoribosyltransferase:1||HOMAIR:1||LPO:1||type2 diabetic rats:1||Plasminogen Activator Inhibitor 1:1||vascular endothelial growth factor:1||Enalapril:1||Glomerulonephritis:1||Renal Insufficiency:1||adipose tissue:1||DA1229:1||Advanced renal dysfunction:1||Purinergic P1 receptor agonists:1||AKI:1||Renalase:1||Diabetes complications:1||NADPH oxidases:1||allcause mortality:1||chronic kidney disease:1||Adriamycin:1||hepatic stellate cell:1||Pentoxifylline:1||Acute kidney injury:1||FATTYACID:1||CHOLESTEROL:1||Parkinsonism:1||chemokine ligand 2:1||metabolic syndrome:1||obesity:1||MCP1:1||PPAR gamma:1||protein kinase B:1||profibrotic molecule:1||Interferons:1||AST120:1||Albumins:1||Antifibrotic drug:1||Lipids:1||VSIG4:1||Chronic kidney failure:1||Molecular biology:1||Nox4:1||myofibroblast:1||Endstage renal disease:1||mitochondria and peroxisome:1||panNox inhibitor:1||Nephropathy:1||Angiotensin II:1||vascular smooth muscle:1||cell proliferation:1||Mitochondria:1||FOODINTAKE:1||ZUCKER RATS:1||HIGA mice:1||Hyponatremia:1||adipose tissue macrophage:1||Adipocytes:1||T helper 2 cells:1||Uremic toxin:1||Nox:1||NOX4:1||Korean Society of Nephrology:1||Kidney Health Plan 2033:1||Immunology:1||Pathology:1||diabetic nephropathies:1||Adiponectin:1||panNADPH oxidases inhibitor:1||antifibrotic drug:1||cAMP:1||HUVECs:1||type 2 diabetic patients:1||Apoptosis:1||ENDOCANNABINOID SYSTEM:1||FA/FA RATS:1||Dysautonomia:1||direct renin inhibitor:1||pentoxifylline:1||Albuminuria:1||Adenosine:1||Biomarker:1||osteoglycin:1||DPPIV:1||CB1 ANTAGONISM:1||Adiposederived stem cells (ASCs):1||CCR2 antagonist:1||Proinflammatory molecule:1||type 2 diabetic patient:1||IGA:1||cyclosporine nephrotoxicity:1||T helper 1 cells:1||Renal outcome:1||Insulin resistance:1||Vset immunoglobulindomain containing 4 protein:1||sepsis:1||stellate cell:1||Oxidative stress:1||Adenosine Receptor Antagonist:1||Sepsis:1||Th1 cytokine:1||Proteinuria:1||Osmotic demyelination:1||chemokine receptor 2:1||Transforming Growth Factor Beta:1||Eplerenone:1||Heme Oxygenase:1||angiotensin receptor antagonist:1||PPAR gamma agonist:1||type 2 diabetes:1||IGA glomerulonephritis:1||H2O2, LPS:1||Mortality:1||Glypicans:1||Glucose variability:1||diabetic kidney disease:1||UUO:1||Type 2 diabetes mellitus:1||Glucocorticoids:1||DIETINDUCED OBESITY:1||ENERGYBALANCE:1||Receptors:1||Angiotensin:1||glucose uptake:1||adipocytokine:1||Cardiovascular outcome:1||renal aging:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE